Qfitlia
Payments companies reported to CMS as associated with Qfitlia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Qfitlia, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Qfitlia
These are the largest totals companies reported as associated with Qfitlia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Guy Young | Bozeman, MT | Pediatric Hematology-Oncology | $115,659.61 |
| Vanessa Salinas-Luna | Orange, CA | Pediatric Hematology-Oncology | $53,776.10 |
| Tammuella Chrisentery-Singleton | New Orleans, LA | Pediatric Hematology-Oncology | $49,941.22 |
| Erin Cockrell | Tampa, FL | Pediatric Hematology-Oncology | $49,365.18 |
| Maissaa Janbain | New Orleans, LA | Hematology & Oncology | $46,152.95 |
| Vinod Balasa | Madera, CA | Pediatric Hematology-Oncology | $45,951.43 |
| Daisy Cortes | Las Vegas, NV | Pediatric Hematology-Oncology | $38,525.83 |
| Jonathan Roberts | Peoria, IL | Pediatrics | $29,981.91 |
| Doris Quon | Los Angeles, CA | Hematology (Internal Medicine) | $25,734.79 |
| Candace Deberry | Tampa, FL | Family | $25,547.81 |
Prescribed Qfitlia?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.